- Board Change
- Results of AGM
- Positive FDA Feedback to Progress Bexmarilimab
- Notice of Faron Pharmaceuticals Ltdâ€™s AGM
- FaronÂ´s Annual Report 2022 Published
- Financial Statement January 1 to December 31 2022
- Update to Faronâ€™s Financial Calendar for 2023
- Notice of 2022 Full-Year Results and Annual Report
- Holding(s) in Company
- Results of Placing
Faron Pharmaceuticals Oy (FARN:LSE) closed at 315.00, -20.25% below its 52-week high of 395.00, set on Dec 07, 2022.
155.00Oct 18 2022395.00Dec 07 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||200.83m GBP|
|EPS (TTM)||-0.4596 |
Data delayed at least 20 minutes, as of Mar 24 2023 13:53 BST.